PCM
GUTS icon

Prelude Capital Management’s Fractyl Health GUTS Stock Holding History

Prelude Capital Management’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.17K Sell
11,286
-69,311
-86% -$63.9K ﹤0.01% 1175
2025
Q4 		$177K Buy
80,597
+45,843
+132% +$73.8K 0.01% 1089
2025
Q3 		$55.3K Buy
+34,754
New +$45.1K ﹤0.01% 1101
2025
Q1 		– Sell
-17,401
Closed -$35.8K – 1575
2024
Q4 		$35.8K Buy
+17,401
New +$40.5K ﹤0.01% 1161
2024
Q2 		– Sell
-14,567
Closed -$108K – 1551
2024
Q1 		$108K Buy
+14,567
New +$123K 0.01% 1192

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prelude Capital Management's GUTS Position: Q1 2026 in Review

Prelude Capital Management reduced its Fractyl Health (GUTS) stake by 86% in Q1 2026, selling an estimated $63.9K and leaving 11,286 shares worth $5.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

Prelude Capital Management first reported a position in GUTS in Q1 2024 and has held it in 5 quarters since. The position peaked at $177K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Prelude Capital Management held 11,286 shares of Fractyl Health worth $5.17K as of Q1 2026.
  • Prelude Capital Management sold 69,311 Fractyl Health shares in Q1 2026, an estimated $63.9K.
  • Fractyl Health made up ﹤0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1175 holding.
  • Prelude Capital Management first reported a position in Fractyl Health in Q1 2024 and has held it in 5 quarters since.
  • Prelude Capital Management's Fractyl Health position peaked at $177K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.